NASDAQ:ICAD iCAD (ICAD) Stock Forecast, Price & News $1.34 +0.06 (+4.60%) (As of 12:26 PM ET) Add Compare Share Share Today's Range$1.30▼$1.3450-Day Range$1.14▼$1.4852-Week Range$1.05▼$4.66Volume18,175 shsAverage Volume151,814 shsMarket Capitalization$34.08 millionP/E RatioN/ADividend YieldN/APrice Target$3.90 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media iCAD MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside195.5% Upside$3.90 Price TargetShort InterestHealthy1.03% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingAcquiring Shares$52,000 Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.31 out of 5 starsComputer And Technology Sector233rd out of 618 stocksSurgical & Medical Instruments Industry38th out of 104 stocks 3.5 Analyst's Opinion Consensus RatingiCAD has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $3.90, iCAD has a forecasted upside of 195.5% from its current price of $1.32.Amount of Analyst CoverageiCAD has only been the subject of 4 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted1.03% of the float of iCAD has been sold short.Short Interest Ratio / Days to CoveriCAD has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous month Previous Next 0.0 Dividend Strength Dividend YieldiCAD does not currently pay a dividend.Dividend GrowthiCAD does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ICAD. Previous Next 2.7 News and Social Media Coverage News SentimentiCAD has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 1 news article for iCAD this week, compared to 2 articles on an average week.Search InterestOnly 4 people have searched for ICAD on MarketBeat in the last 30 days. This is a decrease of -56% compared to the previous 30 days.MarketBeat Follows1 people have added iCAD to their MarketBeat watchlist in the last 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, iCAD insiders have bought more of their company's stock than they have sold. Specifically, they have bought $52,000.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders13.50% of the stock of iCAD is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions48.01% of the stock of iCAD is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of iCAD is -2.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of iCAD is -2.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioiCAD has a P/B Ratio of 0.96. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About iCAD (NASDAQ:ICAD) StockiCAD, Inc. is a global medical technology company, which engages in the provision of cancer detection and therapy solutions. It operates through the Cancer Detection and Cancer Therapy segments. The Cancer Detection segment includes image analysis and workflow products. The Cancer Therapy segment relates to radiation therapy products. The company was founded in 1984 and is headquartered in Nashua, NH.Read More Receive ICAD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iCAD and its competitors with MarketBeat's FREE daily newsletter. Email Address ICAD Stock News HeadlinesMay 18, 2023 | finance.yahoo.comiCAD’s ProFound AI Breast Suite Wins U.S. General Services Administration’s AI Healthcare Challenge AwardMay 16, 2023 | marketwatch.comICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast 2023-2030May 30, 2023 | Edge On The Street (Ad)The Graphite Shortage Story You're Not Being ToldGraphite demand for EV batteries is expected to increase 10X from 2020 to 2030. And today, with NO graphite-producing mines in N. America, China has a stranglehold on our graphite supply. That's why the U.S. government is spending billions of dollars to ensure an adequate domestic supply of this metal that's vital for energy independence and national security. May 16, 2023 | msn.comRecap: icad Q1 EarningsMay 14, 2023 | markets.businessinsider.comHere's what Wall Street expects from icad's earnings reportMay 14, 2023 | americanbankingnews.comCritical Contrast: Integrity Applications (NASDAQ:IGAP) & iCAD (NASDAQ:ICAD)May 11, 2023 | marketwatch.comICAD (Intracranial Atherosclerotic Disease) Pathology MarketMay 11, 2023 | finance.yahoo.comNew Long-Term Real-World Research Confirms Xoft Skin eBx is as Safe and Effective as Mohs SurgeryMay 30, 2023 | Edge On The Street (Ad)Is Graphite the New Lithium?Did you know that graphite (NOT lithium) is the largest component of lithium batteries used for EV's? Unfortunately, there are no graphite-producing mines in North America today. This leaves the U.S. at the mercy of China for our vital graphite supply.May 8, 2023 | americanbankingnews.comiCAD (ICAD) to Release Quarterly Earnings on MondayMay 3, 2023 | finance.yahoo.comiCAD Showcases Breast AI Suite at Society of Breast Imaging Symposium, World’s Largest Breast Imaging ConferenceMay 1, 2023 | finance.yahoo.comiCAD to Report First Quarter 2023 Financial Results on May 15, 2023April 25, 2023 | finance.yahoo.comiCAD’s “ProFound Insights, ProFound Impact” Webinar Series to Feature Boca Raton Regional HospitalApril 20, 2023 | finance.yahoo.comNew and Real-World Clinical Evidence Confirms ProFound AI Increases Cancer Detection without Increasing the Rate of Recalls and Reveals Critical Clues to Inform Clinical DecisionsApril 17, 2023 | finance.yahoo.comiCAD Strengthens Leadership Team with Appointment of Chief Financial Officer and New Senior ExecutivesApril 15, 2023 | msn.comJMP Securities Maintains iCAD (ICAD) Outperform RecommendationApril 15, 2023 | markets.businessinsider.comAnalyst Expectations for icad's FutureApril 13, 2023 | markets.businessinsider.comJMP Securities Reaffirms Their Buy Rating on iCAD (ICAD)April 13, 2023 | americanbankingnews.comiCAD (NASDAQ:ICAD) Given New $4.00 Price Target at JMP SecuritiesApril 12, 2023 | marketwatch.comICAD (Intracranial Atherosclerotic Disease) Pathology Market to Expand Substantially Owing to Technological Innovations During 2023 to 2031April 7, 2023 | americanbankingnews.comOppenheimer Trims iCAD (NASDAQ:ICAD) Target Price to $4.00April 6, 2023 | finance.yahoo.comTrade Alert: The Executive Chair Of iCAD, Inc. (NASDAQ:ICAD), Dana Brown, Has Just Spent US$52k Buying A Few More SharesApril 5, 2023 | americanbankingnews.comiCAD, Inc. (NASDAQ:ICAD) Insider Buys $52,000.00 in StockApril 4, 2023 | finance.yahoo.comProFound AI Risk Outperforms Traditional, Widely-Accepted Breast Cancer Risk Models for Both Short-term and Long-term Risk AssessmentsApril 3, 2023 | marketwatch.comICAD (Intracranial Atherosclerotic Disease) Pathology Market Size 2023: Industry Forecast to 2030April 1, 2023 | americanbankingnews.comLake Street Capital Trims iCAD (NASDAQ:ICAD) Target Price to $2.50March 30, 2023 | finance.yahoo.comiCAD, Inc. (NASDAQ:ICAD) Q4 2022 Earnings Call TranscriptSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive ICAD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iCAD and its competitors with MarketBeat's FREE daily newsletter. Email Address ICAD Company Calendar Last Earnings3/28/2023Today5/30/2023Next Earnings (Estimated)8/09/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorComputer and Technology Current SymbolNASDAQ:ICAD CUSIPN/A CIK749660 Webwww.icadmed.com Phone(603) 882-5200Fax603-880-3843Employees136Year FoundedN/APrice Target and Rating Average Stock Price Forecast$3.90 High Stock Price Forecast$6.00 Low Stock Price Forecast$2.50 Forecasted Upside/Downside+204.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($0.54) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-13,660,000.00 Net Margins-53.01% Pretax Margin-53.44% Return on Equity-37.50% Return on Assets-25.58% Debt Debt-to-Equity RatioN/A Current Ratio2.66 Quick Ratio2.28 Sales & Book Value Annual Sales$27.94 million Price / Sales1.17 Cash FlowN/A Price / Cash FlowN/A Book Value$1.38 per share Price / Book0.93Miscellaneous Outstanding Shares25,450,000Free Float22,011,000Market Cap$32.58 million OptionableOptionable Beta1.12 Social Links Key ExecutivesDana R. BrownExecutive Chairman, President & CEOMichelle StrongChief Operations OfficerEric LonnqvistChief Financial OfficerJonathan GoChief Technology OfficerWilliam KeyesSenior Vice President-US Commercial Sales-AIKey CompetitorsOptical CableNASDAQ:OCCAtlis Motor VehiclesNASDAQ:AMVAwareNASDAQ:AWREEnergemNASDAQ:ENCPVirnetXNYSE:VHCView All CompetitorsInsiders & InstitutionsLegato Capital Management LLCSold 112,440 shares on 5/25/2023Ownership: 0.140%Susquehanna International Group LLPSold 14,400 shares on 5/16/2023Ownership: 0.000%Portolan Capital Management LLCBought 583,219 shares on 5/15/2023Ownership: 3.608%Two Sigma Advisers LPSold 41,300 shares on 5/15/2023Ownership: 0.294%Two Sigma Investments LPSold 49,223 shares on 5/15/2023Ownership: 0.079%View All Insider TransactionsView All Institutional Transactions ICAD Stock - Frequently Asked Questions Should I buy or sell iCAD stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for iCAD in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ICAD shares. View ICAD analyst ratings or view top-rated stocks. What is iCAD's stock price forecast for 2023? 4 brokers have issued 1 year price targets for iCAD's shares. Their ICAD share price forecasts range from $2.50 to $6.00. On average, they anticipate the company's stock price to reach $3.90 in the next twelve months. This suggests a possible upside of 204.7% from the stock's current price. View analysts price targets for ICAD or view top-rated stocks among Wall Street analysts. How have ICAD shares performed in 2023? iCAD's stock was trading at $1.83 at the beginning of the year. Since then, ICAD stock has decreased by 30.1% and is now trading at $1.28. View the best growth stocks for 2023 here. When is iCAD's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 9th 2023. View our ICAD earnings forecast. How were iCAD's earnings last quarter? iCAD, Inc. (NASDAQ:ICAD) released its quarterly earnings data on Tuesday, March, 28th. The technology company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by $0.01. The technology company earned $6.49 million during the quarter, compared to analyst estimates of $6.53 million. iCAD had a negative net margin of 53.01% and a negative trailing twelve-month return on equity of 37.50%. What guidance has iCAD issued on next quarter's earnings? iCAD issued an update on its fourth quarter 2022 earnings guidance on Monday, March, 13th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $6.50 million-$6.50 million, compared to the consensus revenue estimate of $6.61 million. What is Michael Klein's approval rating as iCAD's CEO? 4 employees have rated iCAD Chief Executive Officer Michael Klein on Glassdoor.com. Michael Klein has an approval rating of 75% among the company's employees. What other stocks do shareholders of iCAD own? Based on aggregate information from My MarketBeat watchlists, some companies that other iCAD investors own include Inseego (INSG), Marvell Technology (MRVL), NVIDIA (NVDA), Aptiv (APTV), JD.com (JD), Advanced Micro Devices (AMD), Bilibili (BILI), Ambarella (AMBA), BioXcel Therapeutics (BTAI) and Telefonaktiebolaget LM Ericsson (publ) (ERIC). What is iCAD's stock symbol? iCAD trades on the NASDAQ under the ticker symbol "ICAD." Who are iCAD's major shareholders? iCAD's stock is owned by many different retail and institutional investors. Top institutional investors include Granahan Investment Management LLC (8.51%), Portolan Capital Management LLC (3.61%), Greenwood Capital Associates LLC (1.27%), General American Investors Co. Inc. (0.79%), Perritt Capital Management Inc. (0.79%) and Renaissance Technologies LLC (0.75%). Insiders that own company stock include Andy Sassine, Charles Ross Carter, Dana R Brown, Jonathan Go, Michael S Klein, R Scott Areglado, Stacey M Stevens, Susan Alyson Wood and Timothy Norris Irish. View institutional ownership trends. How do I buy shares of iCAD? Shares of ICAD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is iCAD's stock price today? One share of ICAD stock can currently be purchased for approximately $1.28. How much money does iCAD make? iCAD (NASDAQ:ICAD) has a market capitalization of $32.58 million and generates $27.94 million in revenue each year. The technology company earns $-13,660,000.00 in net income (profit) each year or ($0.54) on an earnings per share basis. How many employees does iCAD have? The company employs 136 workers across the globe. How can I contact iCAD? iCAD's mailing address is 98 SPIT BROOK ROAD SUITE 100, NASHUA NH, 03062. The official website for the company is www.icadmed.com. The technology company can be reached via phone at (603) 882-5200, via email at jeremy@lifesciadvisors.com, or via fax at 603-880-3843. This page (NASDAQ:ICAD) was last updated on 5/30/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iCAD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.